Innovation of anti-inflammatory drugs--inhibition of cyclooxygenases.
- Author:
Zong-ru GUO
1
Author Information
1. Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China. zrguo@imm.ac.cn
- Publication Type:Journal Article
- MeSH:
Anti-Inflammatory Agents, Non-Steroidal;
adverse effects;
pharmacology;
Cardiovascular Diseases;
chemically induced;
Celecoxib;
Cyclooxygenase 1;
metabolism;
Cyclooxygenase 2;
metabolism;
Cyclooxygenase 2 Inhibitors;
adverse effects;
pharmacology;
Epoprostenol;
biosynthesis;
Humans;
Lactones;
adverse effects;
pharmacology;
Pyrazoles;
adverse effects;
pharmacology;
Sulfonamides;
adverse effects;
pharmacology;
Sulfones;
adverse effects;
pharmacology;
Thromboxane A2;
metabolism
- From:
Acta Pharmaceutica Sinica
2005;40(11):967-969
- CountryChina
- Language:Chinese
